Khashayar Esfahani

Montreal, QC H3T1E2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Journal: JAMA dermatology

Published: May 27, 2026

JAK inhibitors for the treatment of life-threatening and refractory immune-related adverse events secondary to immune checkpoint inhibitors: a prospective cohort study.

JAK inhibitors for the treatment of life-threatening and refractory immune-related adverse events secondary to immune checkpoint inhibitors: a prospective cohort study.

Journal: Journal for immunotherapy of cancer

Published: November 07, 2025

Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma.

Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: September 30, 2025

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Journal: Oral oncology

Published: August 29, 2025

Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial.

Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial.

Journal: Journal for immunotherapy of cancer

Published: July 15, 2025

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Journal: Head & neck

Published: July 13, 2025

Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity.

Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity.

Journal: Journal of inflammation (London, England)

Published: April 28, 2025

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Journal: Head & neck

Published: March 23, 2025

Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC.

Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC.

Journal: Head & neck

Published: March 20, 2025

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer.

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer.

Journal: Head & neck

Published: March 18, 2025

Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events.

Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events.

Journal: Current oncology (Toronto, Ont.)

Published: December 17, 2024

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Cancer.

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Cancer.

Journal: JAMA otolaryngology-- head & neck surgery

Published: December 05, 2024

Showing 1-12 of 51

Last Updated: 09/26/2026